Scientists at Northwestern University have identified a previously hidden toxic protein that may trigger Alzheimer’s disease ...
The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...
A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...
A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...
New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...
Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.
"If we can attack the disease before those symptoms start, we're doing a major service to the patient and to society." ...
1d
Quanterix Announces Landmark Nature Study Redefining Alzheimer’s Disease Neuropathology Prevalence
Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from ...
Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease (AD) by inhibiting semaphorin 4D (SEMA4D) induced pathology in brain, ...
An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...
Scientists at Northern Arizona University are developing a promising new way to detect Alzheimer’s disease earlier than ever before—by tracking how the brain uses sugar. Using tiny particles in the ...
Recent study finds that 1 in 3 Norwegians over 70 have brain changes associated with Alzheimer's - Anadolu Ajansı ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback